Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Drug Deliv Transl Res. 2012 Feb 1;2(1):45–55. doi: 10.1007/s13346-011-0054-y

Fig. 3.

Fig. 3

Representative gray-scale ultrasound images of implants acquired over a period of 240 h; each row is representative of implants loaded with different drugs: Fluorescein, DiI, BSA, and Dox. The scale bar represents 2.5 mm. Pore formation is indicated with arrows